Related Experiment Video
Updated: May 6, 2026

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
Published on: December 28, 2015
MYC Rearrangement Prediction From LYSA Whole Slide Images in Large B-Cell Lymphoma: A Multicentric Validation of
Charlotte Syrykh1, Valentina Di Proietto2, Eliott Brion2
1Department of Pathology, IUCT Oncopole, Toulouse, France.
A new deep learning algorithm can detect MYC gene rearrangement in large B-cell lymphoma (LBCL) from standard tissue slides. This automated method reduces the need for expensive tests and aids in diagnosing this aggressive cancer.
Area of Science:
- Computational pathology
- Digital pathology
- Oncology
Background:
- Large B-cell lymphoma (LBCL) is a diverse cancer with MYC gene rearrangement (MYC-R) indicating a poor prognosis.
- Current MYC-R detection via fluorescence in situ hybridization (FISH) is costly, slow, and not universally accessible.
Purpose of the Study:
- To develop an automated, interpretable deep learning algorithm for MYC-R detection in LBCL using hematoxylin-and-eosin (H&E) stained whole slide images.
- To reduce reliance on FISH testing and enhance diagnostic efficiency for pathologists.
Main Methods:
- An interpretable deep learning model was created, incorporating self-supervised learning techniques.
- The model was trained and validated on four independent multicentric cohorts comprising 1247 LBCL patients.
- Extensive comparisons were performed across 7 feature extractors and 6 multiple instance learning models.
Main Results:
- The best deep learning model achieved an average AUC of 81.9% on cross-validation and AUCs from 62.2% to 74.5% on unseen cohorts.
- The model demonstrated potential as a prescreening tool, potentially eliminating the need for FISH in 35% of cases with a 0% false-negative rate.
Conclusions:
- Automated MYC-R detection on H&E slides using deep learning is feasible for routine pathology practice.
- This approach offers a cost-effective and efficient alternative to traditional molecular testing for LBCL.
- The developed algorithm could serve as a valuable medical device for improving LBCL diagnosis and patient management.
More Related Videos
08:58Label-Free Identification of Lymphocyte Subtypes Using Three-Dimensional Quantitative Phase Imaging and Machine Learning
Published on: November 19, 2018
07:52Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
Published on: January 9, 2019